EUVIMEDEUVIMED entdecken
Crossref

A New Proposal for Host-Directed Therapy in Ebola Virus Disease: Ozone Autohemotherapy as an Adjunctive Approach Within a Systems Biology Framework

Bilal Mohamad Ali Obeid

Journal of Clinical Immunology & Microbiology · 29.06.2026 · 7 (2) · 1-10

DOI: 10.46889/jcim.2026.7204 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Immunology & Microbiology, online erschienen am 29.06.2026. Verfasst von Bilal Mohamad Ali Obeid. Die Arbeit nennt 27 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ebola Virus Disease (EVD) remains one of the most lethal viral hemorrhagic fevers, with mortality driven not only by viral replication but also by a dysregulated host response characterized by hyperinflammation, endothelial dysfunction, coagulopathy, metabolic derangement and multi-organ failure. Although monoclonal antibodies and vaccination have substantially improved outcomes, currently available interventions primarily target the virus and do not directly address the complex host-response networks that contribute to advanced disease and mortality. Here, we propose a systems biology framework for evaluating Ozone Autohemotherapy (O₃-AHT), specifically Major Autohemotherapy (MAH), as a host-directed adjunctive strategy in EVD. The framework is based on the capacity of O₃-AHT to generate controlled redox signals through Reactive Oxygen Species (ROS) and Lipid Ozonation Products (LOPs), which activate adaptive stress-response pathways including the Nrf2/Keap1/Antioxidant Response Element (ARE) system, the AMP-Activated Protein Kinase (AMPK)-Forkhead Box O (FOXO)-mechanistic Target of Rapamycin (mTOR)-sirtuin 1 (Sirt1) axis and Nrf2-mediated modulation of Nuclear Factor Kappa B (NF-κB) signaling. These interconnected pathways regulate antioxidant defenses, mitochondrial adaptation, autophagy, inflammatory responses, endothelial homeostasis and immune regulation-biological processes that intersect with major pathogenic mechanisms of EVD. Particular attention is given to Heme Oxygenase-1 (HO-1), a downstream effector of Nrf2 activation for which experimental evidence demonstrates suppression of Ebola virus replication in-vitro, providing a mechanistic bridge between host-directed redox modulation and antiviral activity. By integrating current knowledge from virology, immunology, redox biology and systems medicine, this framework identifies multiple points of convergence between ozone-induced adaptive signaling and Ebola pathophysiology. This work does not establish clinical efficacy but presents a hypothesis-generating model intended to guide future experimental investigation. As a conceptual framework, it proposes O₃-AHT as a candidate host-directed adjunctive approach that warrants systematic evaluation in preclinical models of Ebola virus disease.

Zitieren

APA

Obeid, B. M. A. (2026). A New Proposal for Host-Directed Therapy in Ebola Virus Disease: Ozone Autohemotherapy as an Adjunctive Approach Within a Systems Biology Framework. Journal of Clinical Immunology & Microbiology, 7(2), 1-10. https://doi.org/10.46889/jcim.2026.7204

Vancouver

Obeid BMA. A New Proposal for Host-Directed Therapy in Ebola Virus Disease: Ozone Autohemotherapy as an Adjunctive Approach Within a Systems Biology Framework. Journal of Clinical Immunology & Microbiology. 2026;7(2):1-10. doi:10.46889/jcim.2026.7204

BibTeX
@article{Obeid2026,
  author = {Obeid, Bilal Mohamad Ali},
  title = {A New Proposal for Host-Directed Therapy in Ebola Virus Disease: Ozone Autohemotherapy as an Adjunctive Approach Within a Systems Biology Framework},
  journal = {Journal of Clinical Immunology & Microbiology},
  year = {2026},
  volume = {7},
  number = {2},
  pages = {1--10},
  doi = {10.46889/jcim.2026.7204}
}
Kostenlos starten →